1 US.NMH.08.09.029 © 2008 sanofi-aventis U.S. LLC Government Digest.

Slides:



Advertisements
Similar presentations
TABLE OF CONTENTS CHAPTER 1.0: Trends in the Overall Health Care Market Chart 1.1: Total National Health Expenditures, 1980 – 2005 Chart 1.2: Percent Change.
Advertisements

Presenting Medicare 101 and Kaiser Permanente Senior Advantage (HMO) Welcome to Kaiser Permanente Gwinnett County Government Anni Kuechenmeister Medicare.
1 Introduction to the Medical Billing Cycle Chapter One lecture 2 OT 232.
The Health Care Industry Part 2 - Medical Insurance Karen F. Nichols, MSA School of Allied Health Professions University of Nebraska Medical Center.
MEDICARE: PAST, PRESENT AND FUTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.
MEDICARE: PAST, PRESENT AND F UTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.
Congressional Budget Office Presentation to the National Health Policy Conference The Outlook for Health Care Spending February 4, 2008.
Beyond Health Care: The Economic Contribution of Hospitals July 2006.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health? Get Educated, Get Enrolled An.
1 Managed Care Digest Series ®, © 2013 sanofi-aventis U.S., A SANOFI COMPANY Data source: IMS Health © 2013 US.NMH Practice and Hospital Site.
Health Care Financing and Managed Care. Objectives  To understand the basics of health care financing in the United States  To understand the basic.
National Health Expenditure Projections, 2014–24: Spending Growth Faster Than Recent Trends Sean P. Keehan, Gigi A. Cuckler, Andrea M. Sisko, Andrew J.
MEDICARE PRESCRIPTION DRUG BENEFIT Presented by Juliette Cubanski, Ph.D. Principal Policy Analyst Medicare Policy Project The Henry J. Kaiser Family Foundation.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?
What’s in the Mail? Overview of Medicare Prescription Drug Coverage Beneficiary Communications Employer Forum Conference Call October 13, 2005.
MEDICARE PART D Are We Ready? Are We Ready?. Medicare Part D Overview Medicare Part A and B covers individuals Age 65 and older Age 65 and older Those.
The Affordable Care Act Early Impacts. The main provisions of the law do not launch until However, a lot of change has taken place. Dependent Coverage:
(c) 2012 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.
Overview of CMS CMS Headquarters DHHS Secretary Kathleen Sebelius.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
Excess cost growth in Medicare, Medicaid, and all other health care spending Source: CBO, A Federal Perspective on Health Care Policy and Costs, 2008.
Medicare Advantage Overview Diane Rowland, Sc.D. Executive Vice President Kaiser Family Foundation Alliance for Health Reform July 16, 2007.
The ABC&D’s of Medicare. What is Medicare? Medicare is health insurance for: People 65 or older People under 65 with certain disabilities People of any.
Utah’s Primary Care Network A health insurance access initiative Gene Davis Democratic Whip Utah State Senate.
Snapshot of IMS LifeLink Claims Database 10% Random Sample
Medicare Part D and the Financial Protection of the Elderly Gary V. Engelhardt Syracuse University Jonathan Gruber MIT.
Page 1 Overview of Self-Funded Health Plans a step ahead McNeary, Inc.
Agribusiness Library LESSON: HEALTH INSURANCE. Objectives 1. Determine the function of health insurance, and define common health insurance terms. 2.
 The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27,
Additional copies of this report are available on The American Hospital Association’s web site at
THE COMMONWEALTH FUND Medicare Part D: What Are The Concerns? Stuart Guterman Director, Program on Medicare’s Future The Commonwealth Fund Association.
Return to Tutorials Tricia Neuman, Sc.D. Director, Medicare Policy Project Vice President, Kaiser Family Foundation For KaiserEDU June 2009 Medicare 101:
Chart 1.1: Total National Health Expenditures, 1980 – 2011 (1) Source: Centers for Medicare & Medicaid Services, Office of the Actuary. Data released.
Avalere Health LLC | The intersection of business strategy and public policy The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries.
Chartbook 2005 Trends in the Overall Health Care Market Chapter 1: Trends in the Overall Health Care Market.
MEDICARE ADVANTAGE: WHAT CONGRESS INTENDED? by Marsha Gold, Sc.D. Senior Fellow Mathematica Policy Research June 3, 2007 For presentation at Panel on “Medicare.
Appendices. Appendix 1: Supplementary Data Tables Trends in the Overall Health Care Market.
MEDICARE’S 2006 TAKEOVER OF PRESCRIPTION DRUG COVERAGE FOR DUAL ELIGIBLES IN NURSING FACILTIES: ISSUES AND CONCERNS Jim Verdier Mathematica Policy Research,
1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.
1 Managed Care Digest Series ®, © 2012 sanofi-aventis U.S., A SANOFI COMPANY US.NMH
1.03 Healthcare Finances. Health Insurance Plans Premium-The periodic amount paid to an insurance company for healthcare or prescription drugs Deductible-Amount.
Chart 1.1: Total National Health Expenditures, 1980 – 2013 (1) Source: Centers for Medicare & Medicaid Services, Office of the Actuary. Data released.
Appendices. Appendix 1: Supplementary Data Tables Trends in the Overall Health Care Market.
Avalere Health LLC | The intersection of business strategy and public policy The Impact of Enrollment in the Medicare Prescription Drug Benefit on Premiums.
The Third National Medicare Congress Marketplace Assessment of Drug Plan Options: MA-PDs and PDPs Scott G. Hughes R.Ph. October 17, 2006.
The History of Managed Care Organizations in the United States Presentation Developed for the Academy of Managed Care Pharmacy Updated February 2015.
John R. Kasich, Governor Mary Taylor, Lt. Governor/Director Presented by Medicare & You.
1 Data source: Hospitals/Systems Digest Managed Care Digest Series ® 2009 © 2009 sanofi-aventis U.S. LLC US.NMH Hospitals/Systems Digest.
© 2008 sanofi-aventis U.S. LLC HMO-PPO Digest 1. © 2008 sanofi-aventis U.S. LLC Overall enrollment in HMOs nationwide increased after seven consecutive.
MARCH 2016MASSACHUSETTS MEDICAID POLICY INSTITUTE MASSHEALTH: THE BASICS ENROLLMENT UPDATE AS OF NOVEMBER 2015.
Overview of the Medicare Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser Family.
Financial Issues Chapter 14. Financial Issues Financial issues have a substantial influence on health care and pharmacy practice. In 1985 the average.
Medicare Prescription Drug Coverage Tim Cutler, PharmD Marilyn Stebbins, PharmD Clinical Pharmacists Mercy Medical Group - a service of CHW Medical Foundation.
A Summary of Insurance Coverage Chapter 2. 2 Overview Extent and nature of coverage Extent and nature of coverage Employer sponsored Employer sponsored.
Peterson-Kaiser Health System Tracker What are the recent and forecasted trends in prescription drug spending?
Trends in the Overall Health Care Market CHAPTER 1.
Private Insurance Payers and Plans Chapter 3
Medicare, Medicaid, and CHIP
Medication Therapy Management (MTM)
Medicare and Medicaid Week 3.
Growth in prescription spending had slowed, but increased rapidly in 2014 and 2015
Per Enrollee Growth in Medicare Spending and Private Health Insurance Premiums (for Common Benefits), NOTE: Per enrollee includes primary.
MASSHEALTH: THE BASICS enrollment update as of SEPTEMBER 2016
Chart 1.17: Medicare Enrollees,(1) 1995 – 2015
The Third National Medicare Congress David B. Snow, Jr.
Chart 6.8: Percent of Total Regional Employment(1) by Hospitals, 2014
How much is health spending expected to grow?
Presented by Tricia Neuman, Sc.D.
Medicare Reform: Implications for Pharmaceutical Manufacturers
How much is health spending expected to grow?
Presentation transcript:

1 US.NMH © 2008 sanofi-aventis U.S. LLC Government Digest

2 US.NMH © 2008 sanofi-aventis U.S. LLC Medicare Overview Of the nearly 8.7 million Medicare beneficiaries receiving their benefits through Medicare Advantage plans at year-end 2007, 5.7 million (66.1%) were enrolled in HMO risk plans. Between 2006 (5.5 million) and 2007 (6.2 million), the number of Medicare beneficiaries enrolled in HMOs increased 11.6%, the third consecutive annual rise. For the first time since the Digest began tracking this measure, more than half (227 of 443, or 51.2%) of all HMOs operating in the U.S. enrolled Medicare beneficiaries, up notably from 43.5% (195 of 448) the previous year.

3 US.NMH © 2008 sanofi-aventis U.S. LLC Medicare Advantage Enrollment, by Region, 2007 Mid-Atlantic Pacific South Atlantic South Central Mountain East North Central West North Central New England

4 US.NMH © 2008 sanofi-aventis U.S. LLC Medicare HMO Enrollment, by Size Total Number of Medicare HMO Members HMO Membership Size <15,00081,322107,785 15,000–24,999115,758107,849 25,000–49,999243,271389,358 50,000–99,999590,273557, ,000–249,9991,316,4681,220, ,000+3,348,5843,799,471 TOTAL5,539,9546,182,199

5 US.NMH © 2008 sanofi-aventis U.S. LLC Medicare HMO Utilization* Utilization for Medicare HMO Members Utilization Measure Hospital Days/1,000 Medicare HMO Members 1,5291,497 Average Length of Stay (days) per Medicare Hospital Admission Physician Encounters per Medicare HMO Member** Ambulatory Visits per Medicare HMO Member** * Only HMOs that enroll Medicare beneficiaries are included. ** Ambulatory visits differ from physician encounters. Ambulatory visits are visits by an HMO member to an HMO clinic or physician’s office that do not require the services of a physician. Such visits are usually made for tests, prescription refills, immunizations, etc. The term “physician encounter” is self-explanatory. The number of ambulatory visits added to the number of physician encounters gives the total number of encounters.

6 US.NMH © 2008 sanofi-aventis U.S. LLC Medicare HMO Operations* PCPs per 1,000 HMO Members Specialists per 1,000 HMO Members * Only HMOs that enroll Medicare beneficiaries are included. Medicare and non-Medicare HMO enrollees are included in “per 1,000 HMO Members” averages.

7 US.NMH © 2008 sanofi-aventis U.S. LLC Hospital-Based Medicare, 2006 Medicare Patient Percentage Common Diagnoses for Medicare Patients

8 US.NMH © 2008 sanofi-aventis U.S. LLC Medicare HMO Pharmacy Policy* Percentage of HMOs * Only HMOs that enroll Medicare beneficiaries are included.

9 US.NMH © 2008 sanofi-aventis U.S. LLC Medicare Part D Overview Unlike Part A and Part B, Part D drug coverage is available exclusively through plans sponsored by private organizations. Medicare eligibles wishing to obtain drug coverage can choose one of two types of plans: stand-alone prescription drug plans (PDPs), which offer drug coverage only and supplement other Medicare coverage; and Medicare Advantage drug plans (MA-PDs), which combine drug coverage with other Medicare benefits in a single managed care plan.

10 US.NMH © 2008 sanofi-aventis U.S. LLC Enrollment in Medicare Prescription Drug Plans (1),(2) Prescription Drug Plan TypeTotal Stand-Alone Prescription Drug Plan17,340,553 Medicare Advantage with Rx Plans7,645,083 Dual-Eligibles6,645,721 Other Creditable Coverage (3),(4) 5,392,798 Total with Creditable Drug Coverage37,024,155 Total Medicare Beneficiaries43,571,486 % of Total Beneficiaries with Coverage85.0% (1)Part D enrollment data are current as of January 16, 2007, and do not include 410,285 enrollees in U.S. territories. (2)Enrollment totals exclude an estimated 4.9 million with creditable drug coverage for whom data were unavailable. (3)Alternative coverage is deemed to be creditable when it meets or exceeds the actuarial value of the Part D benefit. (4)Other sources of creditable drug coverage for Medicare enrollees include Medicare subsidized employer or union sponsored plans, TRICARE retiree coverage, FEHBP retiree coverage, and other forms of federal coverage.

11 US.NMH © 2008 sanofi-aventis U.S. LLC Medicare Payer Share of Total Prescriptions Dispensed, by Drug Class, 2008* % of Total Prescriptions * Data are as of midyear 2008 and represent the percentages of prescriptions dispensed, by drug class, to all patients.

12 US.NMH © 2008 sanofi-aventis U.S. LLC Percentage of Total Prescriptions Dispensed, by Payer, 2008 Percentage of Total Prescriptions Dispensed Drug Class MedicareMedicaidThird PartyCash Allergies 7.3%8.7%80.0%4.0% Arthritis 11.9%7.3%72.9%7.9% Asthma 11.5%13.4%70.9%4.1% Cholesterol 17.0%5.1%74.5%3.5% Depression 11.4%7.8%74.0%6.7% Diabetes 17.8%7.2%68.9%6.0% Gastrointestinal 13.9%7.7%69.5%8.8% Hypertension 19.7%5.7%67.2%7.5% Oncology 17.8%5.9%71.3%4.9% Osteoporosis 21.4%5.4%71.1%2.0%

13 US.NMH © 2008 sanofi-aventis U.S. LLC Medicaid Overview For the first time since the Digest began tracking this measure, the total number of Medicaid recipients enrolled in MCOs nationwide fell in 2007, to 28.5 million from 28.9 million in Of these 28.5 million Medicaid MCO members nationwide, 19.5 million (68.4%) were enrolled in HMOs, up notably from 18.4 million (63.6%) in The average number of physician encounters per Medicaid HMO member was 4.1 in 2007, up 10.8% from 3.7 in 2006.

14 US.NMH © 2008 sanofi-aventis U.S. LLC Medicaid Managed Care Members, by Type of Managed Care Organization Medicaid Recipients, by Membership in Managed Care Organizations 28.5 million Total 2007 Medicaid MCO Members 44.9 million Total 2007 Medicaid Recipients Medicaid Enrollment in Managed Care Organizations PHPs HIOs Medicaid HMOs PCCMs Medicaid Recipients in MCOs Medicaid Recipients Not in MCOs

15 US.NMH © 2008 sanofi-aventis U.S. LLC Medicaid HMO Utilization Utilization Rates for Medicaid Members in HMOs Utilization Measure Hospital Days/1,000 Medicaid HMO Members Average Length of Stay (days) per Medicaid Hospital Admission Physician Encounters per Medicaid HMO Member** Ambulatory Visits per Medicaid HMO Member** 1.7 * Only HMOs that enroll Medicaid beneficiaries are included. ** Ambulatory visits differ from physician encounters. Ambulatory visits are visits by an HMO member to an HMO clinic or physician’s office that do not require the services of a physician. Such visits are usually made for tests, prescription refills, immunizations, etc. The term “physician encounter” is self-explanatory. The number of ambulatory visits added to the number of physician encounters gives the total number of encounters.

16 US.NMH © 2008 sanofi-aventis U.S. LLC Medicaid HMO Operations* PCPs per 1,000 HMO Members Specialists per 1,000 HMO Members * Only HMOs that enroll Medicaid beneficiaries are included. Medicaid and non-Medicaid HMO enrollees are included in “per 1,000 HMO Members” averages.

17 US.NMH © 2008 sanofi-aventis U.S. LLC Hospital-Based Medicaid, 2006 Medicaid Patient Percent Common Diagnoses for Medicaid Patients

18 US.NMH © 2008 sanofi-aventis U.S. LLC Medicaid HMO Pharmacy Policy Percentage of HMOs Pharmacy Policy for HMOs with Medicaid Members* * Only HMOs that enroll Medicaid beneficiaries are included.

19 US.NMH © 2008 sanofi-aventis U.S. LLC Medicaid Payer Share of Total Prescriptions Dispensed, by Drug Class, 2008* % of Total Prescriptions *Data are as of midyear 2008 and represent the percentages of prescriptions dispensed to all patients. **Attention Deficit Hyperactivity Disorder.

20 US.NMH © 2008 sanofi-aventis U.S. LLC Major Trends: Medicare and Medicaid At year-end 2007, 227 of the 443 HMOs in the U.S. (51.2%) enrolled Medicare beneficiaries, up substantially from 195 (43.5%) in Between January 2007 (78.4%) and January 2008 (85.0%), the overall percentage of Medicare beneficiaries with some form of creditable drug coverage grew nearly seven percentage points. The total number of Medicaid recipients enrolled in MCOs nationwide dropped to 28.5 million in 2007 from 28.9 million in 2006, reversing a decade-long trend of growth.